Promise & Peril: The Digital Biomarker Revolution with Chris Lew, Senior Associate at DeciBio Consulting
In this episode, Chris Lew, Senior Associate at DeciBio Consulting, shares his company’s focus on driving disruption and innovation in the precision medicine space. He also talks about his passion for digital health and delivering impactful solutions based on customer needs. Chris is excited about the digital biomarker revolution and lays out the potential benefits of this technology to health care.
We hope you’ll enjoy this interview with Chris as much as we did.
